RED 68 RED68KIT-ARecalls & reported problems
Penumbra, Inc. · Reperfusion Catheter RED 68 Kit, 132cm · Class 2
Data updated Oct 13, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00815948023895), received between Jan 20, 2022 and Jan 20, 2022 — classified as 1 malfunction.
The most frequently reported specific device problem is “Break” (1 report).
1 other recall cover devices cleared under the same FDA submission (K211411); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Break1
- Material Deformation1
- Physical Resistance/Sticking1
Patient problems
- No Clinical Signs, Symptoms or Conditions1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionJan 20, 2022Break; Material Deformation; Physical Resistance/Sticking; Break; Material Deformation; Physical Resistance/Sticking
THE PATIENT WAS UNDERGOING A THROMBECTOMY PROCEDURE IN RIGHT MIDDLE CEREBRAL ARTERY (RMCA) USING A BENCHMARK BMX96 ACCESS SYSTEM (BENCHMARK MAX), A PENUMBRA SYSTEM RED 68 REPERFUSION CATHETER (RED68), A NON-PENUMBRA MICROCATHETER, A NON-PENUMBRA STENT RETRIEVER DEVICE AND A NON-PENUMBRA GUIDEWIRE. DURING THE PROCEDURE, THE PHYSICIAN PLACED THE BENCHMARK MAX THEN ADVANCED THE RED68 THROUGH THE BENCHMARK MAX. IT WAS REPORTED THAT THE RED68 WOULD NOT ADVANCE PAST THE OPHTHALMIC ARTERY. THEREFORE, THE PHYSICIAN ADVANCED THE MICROCATHETER AND STENT RETRIEVER DEVICE THROUGH THE RED68 AND SUCCESSFULLY COMPLETED FIVE PASSES. AFTER COMPLETING THE LAST PASS, THE PHYSICIAN EXPERIENCED RESISTANCE WHILE RETRACTING THE RED68. AFTER FEW ATTEMPTS TO RETRACT THE RED68 THE PHYSICIAN PULLED HARDER AND HEARD A NOISE. NEXT, THE PHYSICIAN REMOVED THE STENT RETRIEVER DEVICE AND THE RED68, THEN NOTICED THE RED68 TO BE FRACTURED AND STRETCHED AT APPROXIMATELY 110 CM FROM THE HUB. THE PROCEDURE WAS COMPLETED AT THIS POINT. POST ANGIOGRAPHY SHOWED THAT NO PART OF RED68 WAS LEFT INSIDE THE PATIENT. THERE WAS NO REPORT OF AN ADVERSE EFFECT TO THE PATIENT.
Patient problems: No Clinical Signs, Symptoms or Conditions
MAUDE report 13309042 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K211411. One submission often covers many models, so check the product and lot details in each record.
- Z-2770-2026 · Jun 3, 2026 · Open, ClassifiedPenumbra System RED 68 Reperfusion Catheter REF: RED68KIT
Other Catheter, Thrombus Retriever devices
- Penumbra System 5MAXJET7KIT-BPenumbra, Inc. · Catheter, Thrombus Retriever1 recall14 deaths221 reports
- Penumbra System 3MAXCPenumbra, Inc. · CATHETER, THROMBUS RETRIEVER1 death241 reports
- EMBOTRAP ET309537Neuravi Limited · Catheter, Thrombus Retriever13 deaths177 reports
- ACE 5MAXACE068KITPenumbra, Inc. · CATHETER, THROMBUS RETRIEVER170 reports
- Embotrap ET009533Neuravi Limited · Catheter, Thrombus Retriever16 deaths153 reports
- Penumbra System 5MAXACE132Penumbra, Inc. · CATHETER, THROMBUS RETRIEVER3 deaths112 reports
- Penumbra System 5MAXJET7KIT-APenumbra, Inc. · Catheter, Thrombus Retriever1 death94 reports
- Trevo XP 90185Stryker Corporation · CATHETER, THROMBUS RETRIEVER1 recall1 death40 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 13, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 13, 2026
- Page last rebuilt: Oct 13, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page